DAPAGLIFLOZIN

DAPAGLIFLOZIN was reported 60512 times

DAPAGLIFLOZIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 404 0.7240
1 IMMUNISATION 257 0.5922
2 PALMOPLANTAR KERATODERMA 394 0.5434
3 PRURITUS GENITAL 526 0.2232
4 TESTICULAR ABSCESS 28 0.2105
5 SCROTAL ABSCESS 77 0.2037
6 ATRIAL TACHYCARDIA 406 0.1931
7 STEROID DEPENDENCE 169 0.1925
8 DIABETIC KETOSIS 73 0.1921
9 CATARRH 172 0.1903
10 KETOSIS 205 0.1889
11 EUGLYCAEMIC DIABETIC KETOACIDOSIS 779 0.1885
12 GLUCOSE URINE 25 0.1667
13 GENITAL INFECTION 48 0.1455
14 NECROTISING SOFT TISSUE INFECTION 32 0.1385
15 PHIMOSIS 97 0.1316
16 BALANOPOSTHITIS 108 0.1314
17 BLOOD KETONE BODY INCREASED 93 0.1191
18 CAROTID ARTERY OCCLUSION 411 0.1125
19 GENITAL ABSCESS 45 0.1114
20 PERINEAL ABSCESS 50 0.1109
21 BURNS SECOND DEGREE 175 0.0997
22 ACETONAEMIA 24 0.0952
23 LIPOPROTEIN (A) INCREASED 31 0.0948
24 SLEEP TERROR 395 0.0937
25 GLUCOSE URINE PRESENT 118 0.0928
26 TENSION HEADACHE 398 0.0925
27 GENITAL ERYTHEMA 44 0.0887
28 GENITAL INFECTION FUNGAL 73 0.0884
29 GENITAL SWELLING 61 0.0883
30 URINE KETONE BODY PRESENT 136 0.0861
31 KETONURIA 63 0.0774
32 KETOACIDOSIS 576 0.0769
33 NECROTISING FASCIITIS 255 0.0723
34 GLOMERULAR FILTRATION RATE ABNORMAL 99 0.0699
35 DIABETIC KETOACIDOSIS 1648 0.0685
36 POLYCYTHAEMIA 140 0.0678
37 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 88 0.0626
38 GLOMERULAR FILTRATION RATE INCREASED 51 0.0617
39 TYPE V HYPERLIPIDAEMIA 30 0.0617
40 DILATED CARDIOMYOPATHY 62 0.0613
41 GROIN ABSCESS 68 0.0577
42 URINARY TRACT INFECTION FUNGAL 33 0.0575
43 CONGENITAL HYDROCEPHALUS 28 0.0552
44 HEART FAILURE WITH REDUCED EJECTION FRACTION 29 0.0542
45 MICROALBUMINURIA 40 0.0529
46 PERINEAL PAIN 37 0.0517
47 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 61 0.0509
48 GLYCOSURIA 68 0.0503
49 HYPOPNOEA 174 0.0501
50 GENITAL RASH 68 0.0476
51 GLOMERULAR FILTRATION RATE DECREASED 580 0.0472
52 DIABETIC METABOLIC DECOMPENSATION 65 0.0468
53 FACIAL PAIN 408 0.0457
54 MARASMUS 65 0.0427
55 ALCOHOL POISONING 114 0.0425
56 FUNGAL INFECTION 1396 0.0418
57 CARDIAC FAILURE CHRONIC 177 0.0415
58 CARDIAC AMYLOIDOSIS 45 0.0409
59 SUBARACHNOID HAEMORRHAGE 415 0.0407
60 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 45 0.0405
61 ORCHITIS 43 0.0400
62 VASCULITIS 449 0.0385
63 GENITAL PAIN 52 0.0352
64 HYPOGLYCAEMIC COMA 96 0.0333
65 SCROTAL SWELLING 31 0.0331
66 PERIRECTAL ABSCESS 36 0.0325
67 FUNGAL SEPSIS 26 0.0313
68 VULVOVAGINAL CANDIDIASIS 42 0.0310
69 VENTRICULAR TACHYCARDIA 511 0.0309
70 GASTROINTESTINAL HYPOMOTILITY 67 0.0297
71 GENITAL BURNING SENSATION 25 0.0288
72 PENILE SWELLING 35 0.0286
73 ANOSMIA 408 0.0282
74 VULVOVAGINAL PRURITUS 142 0.0280
75 BRONCHIECTASIS 184 0.0273
76 CAROTID ARTERIOSCLEROSIS 28 0.0271
77 EPIDIDYMITIS 31 0.0266
78 GLYCOSYLATED HAEMOGLOBIN INCREASED 656 0.0260
79 PAROSMIA 192 0.0254
80 PERICARDITIS 421 0.0250
81 SYSTEMIC CANDIDA 61 0.0243
82 CARDIAC VENTRICULAR THROMBOSIS 31 0.0240
83 TESTICULAR SWELLING 30 0.0237
84 GLYCOSYLATED HAEMOGLOBIN DECREASED 37 0.0230
85 DIABETES MELLITUS INADEQUATE CONTROL 406 0.0229
86 CARDIAC MURMUR 198 0.0229
87 LEFT ATRIAL DILATATION 29 0.0227
88 VULVOVAGINAL MYCOTIC INFECTION 89 0.0226
89 RHINITIS 181 0.0224
90 GINGIVAL PAIN 178 0.0223
91 OBSTRUCTIVE SLEEP APNOEA SYNDROME 32 0.0219
92 BODY MASS INDEX INCREASED 29 0.0215
93 UROSEPSIS 195 0.0211
94 HYPERKALAEMIA 722 0.0206
95 FOOT AMPUTATION 29 0.0199
96 ESSENTIAL HYPERTENSION 36 0.0197
97 EJECTION FRACTION ABNORMAL 24 0.0196
98 URINE ABNORMALITY 89 0.0196
99 BLOOD CREATINE INCREASED 85 0.0192
100 IMPAIRED GASTRIC EMPTYING 256 0.0188
101 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 76 0.0186
102 URINE OUTPUT INCREASED 48 0.0184
103 POLYURIA 147 0.0179
104 BLOOD CREATININE ABNORMAL 62 0.0179
105 EJECTION FRACTION DECREASED 278 0.0179
106 EXTREMITY NECROSIS 31 0.0178
107 MUSCLE TWITCHING 409 0.0177
108 METABOLIC ACIDOSIS 564 0.0176
109 BLINDNESS 717 0.0176
110 ANAL ABSCESS 93 0.0172
111 PROTEIN URINE PRESENT 86 0.0172
112 DIPLOPIA 440 0.0169
113 RECTAL ABSCESS 28 0.0167
114 LACTIC ACIDOSIS 540 0.0167
115 LEFT VENTRICULAR DYSFUNCTION 111 0.0166
116 POLLAKIURIA 685 0.0164
117 DIABETIC FOOT 48 0.0157
118 PAIN OF SKIN 420 0.0156
119 METABOLIC ALKALOSIS 25 0.0156
120 CARDIAC DYSFUNCTION 58 0.0156
121 TOE AMPUTATION 79 0.0155
122 TUBULOINTERSTITIAL NEPHRITIS 291 0.0155
123 HYPERNATRAEMIA 77 0.0154
124 DIABETIC NEPHROPATHY 34 0.0154
125 BLOOD GLUCOSE ABNORMAL 285 0.0154
126 HYPERVOLAEMIA 76 0.0154
127 LIP SWELLING 511 0.0153
128 CARDIAC FAILURE 1222 0.0152
129 PANCREATITIS NECROTISING 34 0.0148
130 CARDIAC FAILURE ACUTE 98 0.0147
131 HAEMOGLOBIN INCREASED 67 0.0147
132 NEPHRITIS 49 0.0147
133 CUSHINGOID 47 0.0146
134 HYPOVOLAEMIA 85 0.0145
135 ACIDOSIS 111 0.0145
136 HYPERTENSIVE HEART DISEASE 27 0.0144
137 THROAT CLEARING 54 0.0144
138 TRANSIENT ISCHAEMIC ATTACK 485 0.0144
139 RASH PAPULAR 322 0.0144
140 THIRST 254 0.0142
141 POLYDIPSIA 56 0.0142
142 INABILITY TO AFFORD MEDICATION 139 0.0140
143 BRAIN NATRIURETIC PEPTIDE INCREASED 43 0.0139
144 LUPUS NEPHRITIS 26 0.0139
145 WHITE BLOOD CELLS URINE POSITIVE 26 0.0138
146 TINNITUS 632 0.0137
147 EYE PRURITUS 460 0.0137
148 DIASTOLIC DYSFUNCTION 42 0.0136
149 ACUTE KIDNEY INJURY 2047 0.0134
150 BLOOD BICARBONATE DECREASED 25 0.0132
151 VAGINAL INFECTION 62 0.0132
152 HAEMATOCRIT INCREASED 30 0.0132
153 GANGRENE 79 0.0131
154 IMPAIRED QUALITY OF LIFE 186 0.0129
155 PENIS DISORDER 32 0.0129
156 MICTURITION URGENCY 146 0.0128
157 VENTRICULAR HYPOKINESIA 41 0.0128
158 PYELONEPHRITIS ACUTE 25 0.0127
159 ABSCESS LIMB 54 0.0127
160 URINARY TRACT DISORDER 56 0.0124
161 MICTURITION DISORDER 43 0.0124
162 ORTHOPNOEA 39 0.0122
163 RENAL IMPAIRMENT 1024 0.0122
164 AORTIC STENOSIS 42 0.0120
165 URINE ANALYSIS ABNORMAL 36 0.0120
166 DIABETIC NEUROPATHY 59 0.0119
167 PROSTATITIS 36 0.0118
168 RED CELL DISTRIBUTION WIDTH INCREASED 49 0.0118
169 PYELONEPHRITIS 102 0.0118
170 DIZZINESS POSTURAL 114 0.0117
171 CANDIDA INFECTION 198 0.0117
172 RENAL PAIN 124 0.0117
173 HYPOVOLAEMIC SHOCK 56 0.0117
174 BLOOD GLUCOSE FLUCTUATION 128 0.0117
175 ANGIOEDEMA 516 0.0117
176 HYPOGLYCAEMIA 562 0.0116
177 HYPERLACTACIDAEMIA 31 0.0115
178 DIABETIC RETINOPATHY 39 0.0115
179 RENAL TUBULAR ACIDOSIS 25 0.0114
180 URINARY TRACT OBSTRUCTION 27 0.0114
181 BLOOD POTASSIUM INCREASED 183 0.0113
182 IMMUNE-MEDIATED MYOSITIS 31 0.0112
183 MITRAL VALVE INCOMPETENCE 127 0.0112
184 DEHYDRATION 1491 0.0112
185 PROTEINURIA 212 0.0111
186 HYPERURICAEMIA 45 0.0109
187 BLOOD GLUCOSE INCREASED 2009 0.0107
188 DUODENAL ULCER HAEMORRHAGE 30 0.0105
189 DEMENTIA 292 0.0104
190 PULMONARY PAIN 30 0.0103
191 COGNITIVE DISORDER 476 0.0102
192 RETROPERITONEAL HAEMORRHAGE 25 0.0101
193 VENTRICULAR ARRHYTHMIA 37 0.0101
194 DEVICE INFUSION ISSUE 25 0.0101
195 DYSLIPIDAEMIA 51 0.0100
196 HEPATIC CYTOLYSIS 128 0.0100
197 PANCREATITIS ACUTE 224 0.0100
198 DEATH 8511 0.0099
199 PENILE PAIN 30 0.0098
200 PROTEIN TOTAL INCREASED 26 0.0098
201 VULVOVAGINAL DISCOMFORT 43 0.0097
202 TRICUSPID VALVE INCOMPETENCE 77 0.0097
203 BLOOD UREA INCREASED 161 0.0096
204 DYSURIA 353 0.0096
205 WRONG PATIENT RECEIVED PRODUCT 28 0.0096
206 TESTICULAR PAIN 30 0.0095
207 IMPAIRED WORK ABILITY 201 0.0094
208 LEFT VENTRICULAR FAILURE 32 0.0093
209 PEMPHIGOID 69 0.0091
210 BLOOD LACTIC ACID INCREASED 48 0.0091
211 DISTURBANCE IN ATTENTION 488 0.0090
212 CUTANEOUS VASCULITIS 33 0.0090
213 URINE ODOUR ABNORMAL 53 0.0090
214 CORONARY ARTERY STENOSIS 45 0.0089
215 ATRIOVENTRICULAR BLOCK 69 0.0089
216 RENAL DISORDER 414 0.0089
217 SUPRAVENTRICULAR EXTRASYSTOLES 30 0.0089
218 BLOOD PRESSURE SYSTOLIC DECREASED 40 0.0088
219 ANAL INCONTINENCE 79 0.0088
220 CONCOMITANT DISEASE AGGRAVATED 54 0.0087
221 DIABETES MELLITUS 664 0.0087
222 BLOOD GLUCOSE DECREASED 416 0.0087
223 URINARY TRACT INFECTION 1475 0.0086
224 SWOLLEN TONGUE 269 0.0086
225 ARTERIOSCLEROSIS 81 0.0086
226 PERIPHERAL ISCHAEMIA 35 0.0086
227 LEG AMPUTATION 35 0.0085
228 DEAFNESS 222 0.0085
229 NEAR DEATH EXPERIENCE 28 0.0085
230 LEFT VENTRICULAR HYPERTROPHY 36 0.0084
231 PROSTATOMEGALY 33 0.0084
232 FREQUENT BOWEL MOVEMENTS 226 0.0084
233 THYROID MASS 32 0.0083
234 THYROIDITIS 25 0.0083
235 NEPHROTIC SYNDROME 57 0.0083
236 BLOOD URIC ACID INCREASED 48 0.0083
237 ESCHERICHIA URINARY TRACT INFECTION 35 0.0082
238 SUSPECTED COVID-19 27 0.0082
239 FUNGAL SKIN INFECTION 33 0.0082
240 BLOOD CREATININE INCREASED 531 0.0081
241 POTENTIATING DRUG INTERACTION 27 0.0080
242 HYPERLIPIDAEMIA 96 0.0080
243 ARTERIOSCLEROSIS CORONARY ARTERY 53 0.0080
244 ORTHOSTATIC HYPOTENSION 139 0.0080
245 HYPERGLYCAEMIA 289 0.0079
246 CARDIOMYOPATHY 117 0.0079
247 MEDICATION ERROR 437 0.0079
248 AMNESIA 510 0.0078
249 PALPITATIONS 917 0.0078
250 GOUT 140 0.0078
251 RENAL TUBULAR NECROSIS 76 0.0077
252 CONGESTIVE CARDIOMYOPATHY 32 0.0077
253 NOCTURIA 93 0.0077
254 EXERCISE TOLERANCE DECREASED 44 0.0076
255 WEIGHT FLUCTUATION 79 0.0075
256 BLOOD MAGNESIUM DECREASED 65 0.0075
257 DUODENAL ULCER 53 0.0075
258 TYPE 2 DIABETES MELLITUS 251 0.0074
259 PROTEIN TOTAL DECREASED 28 0.0074
260 HALLUCINATION 560 0.0074
261 VITAMIN B12 DEFICIENCY 30 0.0074
262 SHOCK HAEMORRHAGIC 60 0.0074
263 LOW DENSITY LIPOPROTEIN INCREASED 57 0.0074
264 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
265 WEIGHT DECREASED 2048 0.0073
266 RENAL FUNCTION TEST ABNORMAL 34 0.0073
267 GLUCOSE TOLERANCE IMPAIRED 43 0.0073
268 INTENTIONAL PRODUCT MISUSE 633 0.0072
269 ABNORMAL LOSS OF WEIGHT 49 0.0072
270 MIGRAINE 679 0.0071
271 OVERWEIGHT 38 0.0071
272 VULVOVAGINAL PAIN 34 0.0071
273 AORTIC VALVE INCOMPETENCE 30 0.0070
274 CARDIOGENIC SHOCK 101 0.0070
275 PANCREATITIS 370 0.0070
276 VENTRICULAR EXTRASYSTOLES 72 0.0069
277 CHRONIC KIDNEY DISEASE 526 0.0069
278 MYOCARDIAL INFARCTION 1207 0.0069
279 NIGHTMARE 239 0.0069
280 INTENTIONAL PRODUCT USE ISSUE 604 0.0069
281 HEART RATE INCREASED 681 0.0069
282 ATRIAL FIBRILLATION 666 0.0068
283 IDIOPATHIC PULMONARY FIBROSIS 27 0.0068
284 ATRIAL FLUTTER 54 0.0068
285 URINARY INCONTINENCE 200 0.0067
286 BLOOD PRESSURE ABNORMAL 134 0.0067
287 ATRIOVENTRICULAR BLOCK COMPLETE 45 0.0067
288 ACCIDENTAL OVERDOSE 245 0.0067
289 HYPOTENSION 1342 0.0067
290 BLOOD ALBUMIN DECREASED 53 0.0067
291 HUNGER 93 0.0067
292 RENAL CYST 53 0.0067
293 PERIPHERAL VASCULAR DISORDER 34 0.0066
294 HAEMATURIA 225 0.0066
295 ACUTE MYOCARDIAL INFARCTION 192 0.0065
296 SKIN ULCER 168 0.0065
297 RECTAL HAEMORRHAGE 279 0.0065
298 BLOOD PRESSURE DECREASED 431 0.0065
299 CEREBROVASCULAR ACCIDENT 1098 0.0065
300 DYSPNOEA EXERTIONAL 243 0.0064
301 PERIPHERAL SWELLING 992 0.0064
302 TACHYCARDIA 569 0.0064
303 PROSTATIC DISORDER 35 0.0063
304 VISUAL IMPAIRMENT 786 0.0063
305 ISCHAEMIC STROKE 113 0.0063
306 ABDOMINAL DISCOMFORT 1062 0.0063
307 FLANK PAIN 59 0.0063
308 COVID-19 1101 0.0063
309 BLOOD URINE PRESENT 119 0.0063
310 HYPOMAGNESAEMIA 87 0.0062
311 INSURANCE ISSUE 95 0.0062
312 ERYSIPELAS 31 0.0062
313 BUNDLE BRANCH BLOCK LEFT 26 0.0061
314 INTENTIONAL DEVICE MISUSE 27 0.0061
315 RENAL FAILURE 813 0.0061
316 SYSTEMIC LUPUS ERYTHEMATOSUS 217 0.0061
317 PULSE ABSENT 29 0.0061
318 URINE OUTPUT DECREASED 53 0.0061
319 SPINAL STENOSIS 25 0.0061
320 RALES 35 0.0060
321 CREATININE RENAL CLEARANCE DECREASED 24 0.0060
322 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 287 0.0060
323 OBESITY 95 0.0060
324 DERMATITIS BULLOUS 43 0.0059
325 MUSCULAR WEAKNESS 670 0.0059
326 PANCREATIC DISORDER 29 0.0059
327 CARDIAC FLUTTER 38 0.0059
328 HAEMATOCHEZIA 324 0.0059
329 SEPTIC SHOCK 255 0.0059
330 FLUID INTAKE REDUCED 29 0.0058
331 NECROSIS 32 0.0057
332 VULVOVAGINAL BURNING SENSATION 35 0.0057
333 ECZEMA 299 0.0057
334 HYPERHIDROSIS 735 0.0057
335 COLITIS MICROSCOPIC 27 0.0057
336 CARDIOMEGALY 70 0.0057
337 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 44 0.0057
338 DECREASED ACTIVITY 61 0.0056
339 ILLNESS 582 0.0056
340 CEREBRAL INFARCTION 136 0.0056
341 PRODUCT RESIDUE PRESENT 30 0.0056
342 CARDIAC DISORDER 516 0.0055
343 BRAIN FOG 86 0.0055
344 DERMATITIS ALLERGIC 69 0.0055
345 INJECTION SITE NODULE 60 0.0054
346 FLUID RETENTION 277 0.0054
347 SUBCUTANEOUS ABSCESS 26 0.0054
348 IRON DEFICIENCY ANAEMIA 50 0.0054
349 MEMORY IMPAIRMENT 741 0.0054
350 INCREASED APPETITE 103 0.0054
351 ANGINA UNSTABLE 35 0.0054
352 AGRANULOCYTOSIS 100 0.0054
353 RHABDOMYOLYSIS 224 0.0054
354 COLITIS ULCERATIVE 240 0.0054
355 HYPOACUSIS 231 0.0054
356 URINARY RETENTION 179 0.0054
357 CHEST PAIN 989 0.0053
358 PULMONARY OEDEMA 238 0.0053
359 TYPE 1 DIABETES MELLITUS 32 0.0053
360 ILEUS 66 0.0053
361 TACHYPNOEA 72 0.0053
362 CHOLECYSTITIS ACUTE 30 0.0053
363 SKIN ABRASION 25 0.0053
364 CEREBRAL DISORDER 39 0.0053
365 SKIN ATROPHY 30 0.0052
366 HYPONATRAEMIA 293 0.0052
367 VERTIGO 317 0.0052
368 CARDIAC FAILURE CONGESTIVE 417 0.0052
369 MELAENA 113 0.0051
370 PRODUCT ADMINISTRATION INTERRUPTED 40 0.0051
371 SEASONAL ALLERGY 72 0.0051
372 HYDRONEPHROSIS 38 0.0051
373 INFUSION SITE PAIN 65 0.0050
374 VENTRICULAR FIBRILLATION 56 0.0050
375 COVID-19 PNEUMONIA 59 0.0050
376 INFUSION SITE ERYTHEMA 42 0.0050
377 TORSADE DE POINTES 39 0.0050
378 PULMONARY HYPERTENSION 103 0.0049
379 FOOD CRAVING 26 0.0049
380 DIZZINESS 2464 0.0049
381 PRESYNCOPE 120 0.0049
382 MUSCLE ATROPHY 62 0.0049
383 THERAPY CHANGE 48 0.0049
384 MOUTH SWELLING 28 0.0048
385 OLIGURIA 30 0.0048
386 LIPASE INCREASED 37 0.0048
387 APPETITE DISORDER 32 0.0048
388 ARRHYTHMIA 228 0.0048
389 ANURIA 41 0.0048
390 HYPOCALCAEMIA 90 0.0048
391 ERUCTATION 92 0.0048
392 BRADYKINESIA 28 0.0047
393 SLEEP APNOEA SYNDROME 90 0.0047
394 NEPHROPATHY 44 0.0047
395 DRUG INTERACTION 746 0.0047
396 CORONAVIRUS INFECTION 31 0.0047
397 ANAL FISTULA 25 0.0047
398 HAEMOGLOBIN ABNORMAL 30 0.0047
399 SEPSIS 518 0.0046
400 BLOOD TRIGLYCERIDES INCREASED 82 0.0046
401 DRY SKIN 619 0.0046
402 FEEDING DISORDER 94 0.0046
403 HEPATIC STEATOSIS 86 0.0046
404 BACK PAIN 1072 0.0046
405 PRESCRIBED UNDERDOSE 92 0.0046
406 ABDOMINAL PAIN UPPER 945 0.0046
407 OEDEMA 248 0.0046
408 ELECTROLYTE IMBALANCE 53 0.0046
409 DEEP VEIN THROMBOSIS 294 0.0045
410 MACULAR DEGENERATION 54 0.0045
411 HYPERTHYROIDISM 65 0.0045
412 HEART RATE ABNORMAL 25 0.0045
413 MALNUTRITION 50 0.0045
414 BLOOD SODIUM DECREASED 84 0.0045
415 GASTROENTERITIS 65 0.0044
416 ERECTILE DYSFUNCTION 114 0.0044
417 SHOCK 102 0.0044
418 CONFUSIONAL STATE 716 0.0044
419 OROPHARYNGEAL DISCOMFORT 40 0.0044
420 HYPOKALAEMIA 203 0.0044
421 RESPIRATORY RATE INCREASED 39 0.0044
422 ALTERED STATE OF CONSCIOUSNESS 95 0.0044
423 HEART RATE DECREASED 153 0.0044
424 BLOOD POTASSIUM DECREASED 131 0.0044
425 DEAFNESS UNILATERAL 24 0.0044
426 CHOKING SENSATION 24 0.0043
427 BLOOD PRESSURE DIASTOLIC DECREASED 32 0.0043
428 ADVERSE DRUG REACTION 389 0.0043
429 BLADDER DISORDER 43 0.0043
430 CORONARY ARTERY DISEASE 131 0.0043
431 ACUTE RESPIRATORY FAILURE 83 0.0043
432 BOWEL MOVEMENT IRREGULARITY 33 0.0043
433 PULMONARY MASS 64 0.0043
434 NEOPLASM MALIGNANT 286 0.0043
435 RIGHT VENTRICULAR FAILURE 30 0.0043
436 ARTHRITIS 335 0.0043
437 GLAUCOMA 82 0.0043
438 WALKING AID USER 28 0.0042
439 INFARCTION 29 0.0042
440 RASH MACULO-PAPULAR 94 0.0042
441 CATARACT 251 0.0042
442 ONYCHOCLASIS 29 0.0042
443 GROIN PAIN 37 0.0042
444 OEDEMA PERIPHERAL 513 0.0042
445 HYPOPHOSPHATAEMIA 31 0.0042
446 ACUTE RESPIRATORY DISTRESS SYNDROME 74 0.0042
447 EMPHYSEMA 42 0.0042
448 ENTEROCOLITIS 24 0.0042
449 FEELING ABNORMAL 994 0.0041
450 CELLULITIS 209 0.0041
451 LOCALISED INFECTION 100 0.0041
452 BLOOD IRON DECREASED 49 0.0041
453 VOMITING 1936 0.0041
454 ACUTE CORONARY SYNDROME 34 0.0041
455 VITAMIN D DEFICIENCY 40 0.0041
456 CONTRAINDICATED PRODUCT ADMINISTERED 124 0.0041
457 DECREASED APPETITE 947 0.0041
458 DYSPNOEA 2307 0.0041
459 WHITE BLOOD CELL COUNT ABNORMAL 26 0.0041
460 RETINAL HAEMORRHAGE 29 0.0041
461 INCONTINENCE 43 0.0041
462 SYNCOPE 403 0.0040
463 PULMONARY CONGESTION 53 0.0040
464 CYSTITIS 128 0.0040
465 CORONARY ARTERY OCCLUSION 55 0.0040
466 BLOOD PRESSURE FLUCTUATION 96 0.0040
467 HEART RATE IRREGULAR 90 0.0040
468 PAPULE 28 0.0040
469 CHOLECYSTITIS 47 0.0039
470 INTENTIONAL DOSE OMISSION 112 0.0039
471 PULMONARY EMBOLISM 370 0.0039
472 SCRATCH 41 0.0039
473 KIDNEY INFECTION 76 0.0039
474 HYPOPHAGIA 99 0.0039
475 BLOOD DISORDER 31 0.0039
476 OSTEOMYELITIS 70 0.0039
477 HYPOTHERMIA 39 0.0038
478 DYSGEUSIA 286 0.0038
479 DIARRHOEA 2478 0.0038
480 LIVER INJURY 94 0.0038
481 NEPHROLITHIASIS 174 0.0038
482 LIMB INJURY 103 0.0038
483 FURUNCLE 30 0.0038
484 HYPERTENSION 801 0.0038
485 HICCUPS 31 0.0038
486 RHINORRHOEA 244 0.0038
487 ESCHERICHIA INFECTION 31 0.0038
488 PERICARDIAL EFFUSION 87 0.0038
489 GASTRITIS 99 0.0038
490 BLINDNESS UNILATERAL 53 0.0038
491 HAIR GROWTH ABNORMAL 26 0.0038
492 PRODUCT USE ISSUE 704 0.0037
493 MULTIPLE ORGAN DYSFUNCTION SYNDROME 106 0.0037
494 APHONIA 52 0.0037
495 ORAL CANDIDIASIS 49 0.0037
496 CHROMATURIA 84 0.0037
497 GENERALISED OEDEMA 46 0.0037
498 PERIPHERAL COLDNESS 51 0.0037
499 DRY MOUTH 301 0.0037
500 TASTE DISORDER 75 0.0037
501 PRURITUS 1420 0.0037
502 PARKINSONISM 36 0.0037
503 LIMB DISCOMFORT 114 0.0037
504 TROPONIN INCREASED 28 0.0037
505 PHARYNGEAL SWELLING 36 0.0037
506 DRUG ERUPTION 65 0.0037
507 LIGAMENT SPRAIN 36 0.0036
508 HEPATIC CIRRHOSIS 68 0.0036
509 ABDOMINAL DISTENSION 377 0.0036
510 MALAISE 1581 0.0036
511 INCREASED TENDENCY TO BRUISE 33 0.0036
512 SKIN LACERATION 39 0.0036
513 HYPOKINESIA 52 0.0036
514 MYOCARDITIS 41 0.0036
515 TOXIC SKIN ERUPTION 36 0.0036
516 UPPER GASTROINTESTINAL HAEMORRHAGE 60 0.0036
517 ASPHYXIA 29 0.0035
518 PRODUCT DOSE OMISSION ISSUE 1035 0.0035
519 ASTHENIA 1321 0.0035
520 NEUTROPENIC SEPSIS 25 0.0035
521 MUSCULOSKELETAL DISCOMFORT 60 0.0035
522 BLOOD CHOLESTEROL INCREASED 162 0.0035
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 625 0.0035
524 OXYGEN SATURATION DECREASED 194 0.0034
525 INSOMNIA 919 0.0034
526 ELECTROCARDIOGRAM ABNORMAL 27 0.0034
527 ALOPECIA 675 0.0034
528 FATIGUE 2672 0.0034
529 HAEMODYNAMIC INSTABILITY 26 0.0034
530 COLD SWEAT 60 0.0034
531 CHOLESTASIS 65 0.0034
532 SWELLING FACE 220 0.0034
533 GASTRIC ULCER 64 0.0034
534 PETECHIAE 35 0.0034
535 MYASTHENIA GRAVIS 27 0.0033
536 CONSTIPATION 727 0.0033
537 NERVE INJURY 37 0.0033
538 HIATUS HERNIA 43 0.0033
539 FLATULENCE 188 0.0033
540 NAUSEA 2619 0.0033
541 ARTERIAL OCCLUSIVE DISEASE 26 0.0033
542 DRUG EFFECT LESS THAN EXPECTED 49 0.0033
543 FEELING JITTERY 63 0.0033
544 C-REACTIVE PROTEIN INCREASED 120 0.0033
545 AORTIC ANEURYSM 25 0.0033
546 ACCIDENTAL UNDERDOSE 47 0.0033
547 PLEURAL EFFUSION 198 0.0033
548 DYSSTASIA 95 0.0033
549 EOSINOPHILIA 57 0.0032
550 DRUG-INDUCED LIVER INJURY 102 0.0032
551 NERVE COMPRESSION 30 0.0032
552 CHOLELITHIASIS 106 0.0032
553 LOSS OF CONSCIOUSNESS 414 0.0032
554 BLOOD PRESSURE SYSTOLIC INCREASED 63 0.0032
555 HYPOTHYROIDISM 103 0.0032
556 HEPATITIS 82 0.0032
557 THYROID DISORDER 49 0.0032
558 CIRCULATORY COLLAPSE 54 0.0032
559 HEAD INJURY 100 0.0032
560 ABDOMINAL PAIN 735 0.0032
561 BLOOD PRESSURE INCREASED 483 0.0032
562 RETINAL DETACHMENT 29 0.0032
563 BRADYCARDIA 167 0.0031
564 SLUGGISHNESS 32 0.0031
565 ABSCESS 50 0.0031
566 FALL 1040 0.0031
567 SKIN INFECTION 35 0.0031
568 GASTROOESOPHAGEAL REFLUX DISEASE 251 0.0031
569 EAR DISCOMFORT 32 0.0031
570 GASTROINTESTINAL DISORDER 279 0.0031
571 SCAR 53 0.0031
572 BRAIN INJURY 31 0.0031
573 HYPERBILIRUBINAEMIA 32 0.0031
574 HAEMOPTYSIS 86 0.0031
575 INJECTION SITE EXTRAVASATION 38 0.0031
576 LETHARGY 177 0.0031
577 MYOCARDIAL ISCHAEMIA 35 0.0031
578 WEIGHT INCREASED 687 0.0031
579 BLOOD CREATINE PHOSPHOKINASE INCREASED 88 0.0031
580 FACIAL PARALYSIS 26 0.0030
581 ADRENAL INSUFFICIENCY 37 0.0030
582 BLOOD THYROID STIMULATING HORMONE INCREASED 28 0.0030
583 PULMONARY ARTERIAL HYPERTENSION 44 0.0030
584 GENERAL PHYSICAL HEALTH DETERIORATION 351 0.0030
585 SUPRAVENTRICULAR TACHYCARDIA 29 0.0030
586 DYSPEPSIA 298 0.0030
587 ARTHRALGIA 1259 0.0030
588 PRODUCTIVE COUGH 144 0.0030
589 INJECTION SITE MASS 111 0.0030
590 ANGINA PECTORIS 86 0.0030
591 THERAPY CESSATION 154 0.0030
592 SOMNOLENCE 604 0.0030
593 RENAL INJURY 89 0.0030
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
595 PYREXIA 1028 0.0030
596 FRUSTRATION TOLERANCE DECREASED 24 0.0030
597 MUSCLE SPASMS 545 0.0030
598 SLEEP DISORDER 208 0.0029
599 RASH PRURITIC 159 0.0029
600 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 153 0.0029
601 VITAMIN D DECREASED 25 0.0029
602 POLYNEUROPATHY 35 0.0029
603 SKIN FISSURES 57 0.0029
604 PRODUCT DISTRIBUTION ISSUE 27 0.0029
605 GAIT INABILITY 97 0.0029
606 SKIN HAEMORRHAGE 43 0.0029
607 MYOSITIS 26 0.0029
608 INTESTINAL OBSTRUCTION 109 0.0029
609 CHEST DISCOMFORT 296 0.0029
610 LEUKAEMIA 27 0.0029
611 HIP FRACTURE 92 0.0029
612 HEADACHE 1789 0.0029
613 ANXIETY 807 0.0028
614 PNEUMONIA BACTERIAL 26 0.0028
615 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
616 RASH 1228 0.0028
617 PRODUCT AVAILABILITY ISSUE 64 0.0028
618 HALLUCINATION, VISUAL 59 0.0028
619 MASS 39 0.0028
620 HEPATIC FUNCTION ABNORMAL 104 0.0028
621 INCORRECT DOSE ADMINISTERED BY DEVICE 73 0.0028
622 DRUG LEVEL INCREASED 46 0.0028
623 SWELLING 259 0.0028
624 COUGH 776 0.0028
625 WHITE BLOOD CELL COUNT INCREASED 106 0.0028
626 PNEUMONIA ASPIRATION 69 0.0028
627 DRY THROAT 28 0.0028
628 PNEUMONITIS 75 0.0028
629 BACTERIAL INFECTION 51 0.0027
630 INITIAL INSOMNIA 28 0.0027
631 HAEMORRHOIDS 53 0.0027
632 SECRETION DISCHARGE 34 0.0027
633 BLOOD TEST ABNORMAL 38 0.0027
634 PANCREATIC CARCINOMA 78 0.0027
635 SKIN LESION 74 0.0027
636 SCIATICA 43 0.0027
637 VISION BLURRED 369 0.0027
638 LUNG DISORDER 131 0.0027
639 AUTOIMMUNE DISORDER 26 0.0027
640 HYPERSOMNIA 76 0.0026
641 MUSCULOSKELETAL CHEST PAIN 41 0.0026
642 EATING DISORDER 56 0.0026
643 HAEMATOMA 68 0.0026
644 PRODUCT ADMINISTRATION ERROR 53 0.0026
645 BODY HEIGHT DECREASED 28 0.0026
646 COLON CANCER 39 0.0026
647 PRODUCT DOSE OMISSION IN ERROR 74 0.0026
648 NEUROPATHY PERIPHERAL 248 0.0026
649 APATHY 38 0.0026
650 HYPERCHOLESTEROLAEMIA 25 0.0026
651 THERAPY INTERRUPTED 185 0.0026
652 PNEUMONIA 838 0.0026
653 PAIN 1588 0.0026
654 OCULAR DISCOMFORT 29 0.0026
655 RETCHING 55 0.0026
656 RIB FRACTURE 53 0.0026
657 CARDIAC ARREST 212 0.0026
658 PAIN IN EXTREMITY 755 0.0026
659 MOBILITY DECREASED 184 0.0026
660 POOR QUALITY SLEEP 55 0.0026
661 DYSPHONIA 148 0.0025
662 END STAGE RENAL DISEASE 46 0.0025
663 UNRESPONSIVE TO STIMULI 65 0.0025
664 ULCER 40 0.0025
665 ACCIDENT 30 0.0025
666 LIVER DISORDER 111 0.0025
667 GAIT DISTURBANCE 477 0.0025
668 JAUNDICE 67 0.0025
669 PNEUMOCYSTIS JIROVECII PNEUMONIA 25 0.0025
670 ANAPHYLACTIC SHOCK 64 0.0025
671 OROPHARYNGEAL PAIN 229 0.0025
672 HAEMATOCRIT DECREASED 49 0.0025
673 INFLUENZA 275 0.0025
674 BACK DISORDER 40 0.0025
675 INFECTION 356 0.0025
676 INTERNAL HAEMORRHAGE 28 0.0024
677 DEVICE LEAKAGE 106 0.0024
678 NEUTROPHIL COUNT INCREASED 25 0.0024
679 LIVER FUNCTION TEST ABNORMAL 71 0.0024
680 CONDITION AGGRAVATED 742 0.0024
681 DEPRESSED MOOD 129 0.0024
682 INTERSTITIAL LUNG DISEASE 118 0.0024
683 PRODUCT PRESCRIBING ISSUE 53 0.0024
684 HERNIA 47 0.0024
685 OFF LABEL USE 2128 0.0024
686 BALANCE DISORDER 210 0.0024
687 COLITIS 92 0.0024
688 MYALGIA 409 0.0024
689 CARDIOVASCULAR DISORDER 61 0.0024
690 PRODUCT PRESCRIBING ERROR 57 0.0024
691 SPINAL PAIN 28 0.0024
692 ANAEMIA 455 0.0024
693 GASTROENTERITIS VIRAL 43 0.0024
694 RED BLOOD CELL COUNT DECREASED 68 0.0024
695 DEPRESSION 539 0.0024
696 DERMATITIS CONTACT 27 0.0024
697 HOT FLUSH 178 0.0024
698 INCORRECT PRODUCT ADMINISTRATION DURATION 51 0.0024
699 NEOPLASM 27 0.0023
700 GAMMA-GLUTAMYLTRANSFERASE INCREASED 52 0.0023
701 SPINAL FRACTURE 47 0.0023
702 DIVERTICULITIS 65 0.0023
703 SINUS DISORDER 46 0.0023
704 PROSTATIC SPECIFIC ANTIGEN INCREASED 32 0.0023
705 EYE PAIN 131 0.0023
706 DYSPHAGIA 220 0.0023
707 EPISTAXIS 173 0.0023
708 AGEUSIA 57 0.0023
709 MUSCLE TIGHTNESS 37 0.0023
710 SPEECH DISORDER 119 0.0023
711 TOOTHACHE 41 0.0023
712 BLISTER 127 0.0023
713 TREMOR 374 0.0023
714 HYPERTENSIVE CRISIS 25 0.0022
715 CYTOKINE RELEASE SYNDROME 45 0.0022
716 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
717 QUALITY OF LIFE DECREASED 30 0.0022
718 DYSARTHRIA 84 0.0022
719 NASAL CONGESTION 131 0.0022
720 NEPHROPATHY TOXIC 25 0.0022
721 BLADDER CANCER 131 0.0022
722 FRACTURE 42 0.0022
723 FOOT FRACTURE 42 0.0022
724 UPPER LIMB FRACTURE 44 0.0022
725 BACK INJURY 24 0.0022
726 ILL-DEFINED DISORDER 134 0.0022
727 LABORATORY TEST ABNORMAL 65 0.0022
728 ANKLE FRACTURE 34 0.0022
729 DISCOMFORT 134 0.0022
730 JOINT SWELLING 265 0.0022
731 ASPIRATION 24 0.0022
732 EYE DISORDER 72 0.0022
733 DRUG INTOLERANCE 211 0.0022
734 THROAT IRRITATION 98 0.0022
735 CEREBRAL HAEMORRHAGE 78 0.0022
736 EYE SWELLING 81 0.0022
737 TREATMENT NONCOMPLIANCE 119 0.0022
738 PARALYSIS 31 0.0022
739 FEELING COLD 60 0.0022
740 LEUKOCYTOSIS 39 0.0022
741 JOINT INJURY 46 0.0022
742 CHOKING 42 0.0022
743 RESPIRATORY TRACT INFECTION 56 0.0021
744 PARAESTHESIA ORAL 31 0.0021
745 WOUND 60 0.0021
746 SINUS CONGESTION 29 0.0021
747 HEAD DISCOMFORT 38 0.0021
748 SKIN EXFOLIATION 181 0.0021
749 THROMBOSIS 172 0.0021
750 SKIN DISCOLOURATION 98 0.0021
751 BEDRIDDEN 28 0.0021
752 HEMIPARESIS 36 0.0021
753 FAECES DISCOLOURED 46 0.0021
754 FEELING HOT 130 0.0021
755 SINUS TACHYCARDIA 30 0.0021
756 HYPERCALCAEMIA 26 0.0021
757 MENTAL IMPAIRMENT 51 0.0021
758 NEURALGIA 51 0.0021
759 LIVER FUNCTION TEST INCREASED 45 0.0021
760 SUBDURAL HAEMATOMA 30 0.0021
761 THINKING ABNORMAL 39 0.0021
762 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 424 0.0021
763 CONTUSION 200 0.0021
764 PANCYTOPENIA 116 0.0021
765 BURNING SENSATION 145 0.0021
766 PRODUCT DISPENSING ERROR 45 0.0021
767 ABDOMINAL PAIN LOWER 52 0.0021
768 BLOOD ALKALINE PHOSPHATASE INCREASED 51 0.0021
769 DERMATITIS 43 0.0021
770 THERAPY PARTIAL RESPONDER 32 0.0020
771 HYPOXIA 72 0.0020
772 SARS-COV-2 TEST POSITIVE 27 0.0020
773 LYMPHOCYTE COUNT DECREASED 36 0.0020
774 HERPES ZOSTER 117 0.0020
775 PULMONARY FIBROSIS 39 0.0020
776 LOWER LIMB FRACTURE 39 0.0020
777 INJECTION SITE HAEMORRHAGE 162 0.0020
778 UNDERDOSE 148 0.0020
779 ROTATOR CUFF SYNDROME 26 0.0020
780 EYE HAEMORRHAGE 27 0.0020
781 DISABILITY 40 0.0020
782 APHASIA 61 0.0020
783 GALLBLADDER DISORDER 36 0.0020
784 VIRAL INFECTION 67 0.0020
785 HAEMATEMESIS 51 0.0020
786 HAEMOGLOBIN DECREASED 206 0.0020
787 RESPIRATORY FAILURE 146 0.0020
788 CARPAL TUNNEL SYNDROME 28 0.0020
789 CYANOSIS 31 0.0020
790 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
791 NEEDLE ISSUE 57 0.0020
792 INFLAMMATION 101 0.0020
793 RASH ERYTHEMATOUS 92 0.0019
794 BASAL CELL CARCINOMA 30 0.0019
795 HYPERSENSITIVITY 354 0.0019
796 HEPATIC ENZYME INCREASED 130 0.0019
797 SKIN DISORDER 63 0.0019
798 PRODUCT USE IN UNAPPROVED INDICATION 468 0.0019
799 MOVEMENT DISORDER 60 0.0019
800 DISORIENTATION 74 0.0019
801 URTICARIA 310 0.0018
802 COMA 88 0.0018
803 INTERVERTEBRAL DISC PROTRUSION 40 0.0018
804 BRONCHITIS 135 0.0018
805 STAPHYLOCOCCAL INFECTION 60 0.0018
806 PLATELET COUNT DECREASED 193 0.0018
807 HYPOAESTHESIA 271 0.0018
808 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 31 0.0018
809 LYMPHADENOPATHY 64 0.0018
810 SENSORY DISTURBANCE 29 0.0018
811 THROMBOCYTOPENIA 202 0.0018
812 WHEEZING 107 0.0018
813 RASH MACULAR 63 0.0018
814 TRANSAMINASES INCREASED 40 0.0018
815 MYELODYSPLASTIC SYNDROME 26 0.0018
816 CLOSTRIDIUM DIFFICILE INFECTION 39 0.0018
817 DELIRIUM 62 0.0018
818 SNEEZING 40 0.0018
819 ELECTROCARDIOGRAM QT PROLONGED 64 0.0018
820 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
821 PRODUCT USE COMPLAINT 28 0.0018
822 GASTROINTESTINAL HAEMORRHAGE 148 0.0018
823 POST PROCEDURAL COMPLICATION 34 0.0018
824 MULTIPLE FRACTURES 29 0.0018
825 THERAPY NON-RESPONDER 79 0.0018
826 PHOTOSENSITIVITY REACTION 29 0.0018
827 OSTEOPOROSIS 72 0.0017
828 DEPRESSED LEVEL OF CONSCIOUSNESS 69 0.0017
829 NECK PAIN 97 0.0017
830 EXTRA DOSE ADMINISTERED 70 0.0017
831 SINUSITIS 177 0.0017
832 FACE OEDEMA 29 0.0017
833 ASCITES 50 0.0017
834 ASTHMA 191 0.0017
835 UPPER RESPIRATORY TRACT INFECTION 78 0.0017
836 TENDONITIS 26 0.0017
837 FEMUR FRACTURE 52 0.0017
838 PANIC ATTACK 61 0.0017
839 RESPIRATORY DISORDER 50 0.0017
840 LACRIMATION INCREASED 50 0.0017
841 RESTLESS LEGS SYNDROME 30 0.0016
842 NIGHT SWEATS 53 0.0016
843 ENCEPHALOPATHY 40 0.0016
844 SEIZURE 188 0.0016
845 OSTEOARTHRITIS 69 0.0016
846 MIDDLE INSOMNIA 30 0.0016
847 DISEASE RECURRENCE 75 0.0016
848 MOOD ALTERED 43 0.0016
849 PNEUMOTHORAX 25 0.0016
850 RESPIRATORY TRACT CONGESTION 25 0.0016
851 NERVOUSNESS 82 0.0016
852 ERYTHEMA 320 0.0016
853 IMPAIRED HEALING 51 0.0016
854 THROAT TIGHTNESS 42 0.0016
855 CHILLS 181 0.0015
856 PALLOR 42 0.0015
857 DRY EYE 77 0.0015
858 NASOPHARYNGITIS 281 0.0015
859 BLOOD BILIRUBIN INCREASED 41 0.0015
860 MOOD SWINGS 48 0.0015
861 PARAESTHESIA 235 0.0015
862 IRRITABLE BOWEL SYNDROME 32 0.0015
863 ANAPHYLACTIC REACTION 82 0.0015
864 INJECTION SITE PRURITUS 99 0.0015
865 BONE PAIN 86 0.0015
866 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 68 0.0015
867 OCULAR HYPERAEMIA 69 0.0015
868 VAGINAL HAEMORRHAGE 63 0.0015
869 NERVOUS SYSTEM DISORDER 45 0.0014
870 MUSCULOSKELETAL DISORDER 27 0.0014
871 HAEMORRHAGE 148 0.0014
872 TOOTH LOSS 29 0.0014
873 HEPATIC FAILURE 42 0.0014
874 THERAPEUTIC RESPONSE SHORTENED 46 0.0014
875 ROAD TRAFFIC ACCIDENT 58 0.0014
876 RESPIRATORY DISTRESS 38 0.0014
877 PAIN IN JAW 39 0.0014
878 DEVICE USE ISSUE 24 0.0014
879 BONE DISORDER 25 0.0014
880 DEVICE ISSUE 123 0.0014
881 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
882 LOWER RESPIRATORY TRACT INFECTION 62 0.0014
883 TOOTH DISORDER 30 0.0013
884 IRRITABILITY 81 0.0013
885 EAR PAIN 26 0.0013
886 THERAPEUTIC RESPONSE UNEXPECTED 60 0.0013
887 SKIN IRRITATION 61 0.0013
888 EAR INFECTION 35 0.0013
889 ARTHROPATHY 73 0.0013
890 INCORRECT DOSE ADMINISTERED 297 0.0013
891 LUNG NEOPLASM MALIGNANT 53 0.0013
892 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
893 HOSPITALISATION 194 0.0013
894 STEVENS-JOHNSON SYNDROME 28 0.0013
895 PRODUCT DOSE OMISSION 82 0.0013
896 DEVICE MALFUNCTION 88 0.0013
897 EYE IRRITATION 72 0.0012
898 SURGERY 73 0.0012
899 FULL BLOOD COUNT DECREASED 25 0.0012
900 VISUAL ACUITY REDUCED 41 0.0012
901 INJECTION SITE URTICARIA 30 0.0012
902 INFLUENZA LIKE ILLNESS 100 0.0012
903 DRUG RESISTANCE 31 0.0012
904 FLUSHING 121 0.0012
905 KNEE ARTHROPLASTY 25 0.0012
906 PSORIASIS 155 0.0012
907 MOUTH ULCERATION 25 0.0012
908 ANGER 40 0.0012
909 MENTAL DISORDER 51 0.0012
910 ORAL PAIN 26 0.0012
911 MUSCULOSKELETAL STIFFNESS 101 0.0012
912 FEAR 31 0.0012
913 MENTAL STATUS CHANGES 32 0.0012
914 DRUG INEFFECTIVE 1518 0.0012
915 ACNE 87 0.0011
916 MUCOSAL INFLAMMATION 30 0.0011
917 EPILEPSY 35 0.0011
918 INJECTION SITE BRUISING 91 0.0011
919 DYSKINESIA 46 0.0011
920 PROSTATE CANCER 91 0.0011
921 HEPATOTOXICITY 25 0.0011
922 STOMATITIS 68 0.0011
923 INJECTION SITE PAIN 343 0.0011
924 PSORIATIC ARTHROPATHY 45 0.0011
925 INJECTION SITE RASH 34 0.0011
926 SUICIDAL IDEATION 99 0.0011
927 PLASMA CELL MYELOMA 42 0.0011
928 SUICIDE ATTEMPT 65 0.0011
929 NEUTROPHIL COUNT DECREASED 43 0.0011
930 DISEASE PROGRESSION 124 0.0010
931 DRUG DOSE OMISSION 172 0.0010
932 FEBRILE NEUTROPENIA 69 0.0010
933 RHEUMATOID ARTHRITIS 118 0.0010
934 SEDATION 27 0.0010
935 NEUTROPENIA 139 0.0010
936 INJECTION SITE SWELLING 78 0.0010
937 RESTLESSNESS 37 0.0010
938 ADVERSE EVENT 93 0.0010
939 WHITE BLOOD CELL COUNT DECREASED 109 0.0010
940 RASH GENERALISED 26 0.0010
941 EXPOSURE VIA SKIN CONTACT 25 0.0010
942 TOXICITY TO VARIOUS AGENTS 161 0.0010
943 ANHEDONIA 25 0.0010
944 RENAL CANCER 45 0.0009
945 CRYING 34 0.0009
946 INJECTION SITE ERYTHEMA 112 0.0009
947 PROCEDURAL PAIN 25 0.0009
948 PREMATURE BABY 27 0.0009
949 THERAPEUTIC PRODUCT EFFECT DECREASED 40 0.0009
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
951 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63 0.0009
952 CARDIO-RESPIRATORY ARREST 37 0.0009
953 INFUSION RELATED REACTION 58 0.0009
954 GASTRIC DISORDER 30 0.0009
955 MUSCULOSKELETAL PAIN 45 0.0009
956 INTENTIONAL OVERDOSE 55 0.0009
957 LEUKOPENIA 42 0.0008
958 PRODUCT SUBSTITUTION ISSUE 48 0.0008
959 OVERDOSE 178 0.0008
960 DERMATITIS ATOPIC 43 0.0008
961 INJURY 57 0.0008
962 GYNAECOMASTIA 25 0.0008
963 UNEVALUABLE EVENT 61 0.0008
964 MALIGNANT NEOPLASM PROGRESSION 77 0.0008
965 MYELOSUPPRESSION 27 0.0007
966 THERAPEUTIC RESPONSE DECREASED 44 0.0007
967 AGITATION 53 0.0007
968 DEVICE USE ERROR 25 0.0007
969 NO ADVERSE EVENT 126 0.0007
970 AGGRESSION 34 0.0007
971 BREAST CANCER 62 0.0007
972 FOETAL EXPOSURE DURING PREGNANCY 54 0.0007
973 PRODUCT STORAGE ERROR 56 0.0006
974 ABNORMAL BEHAVIOUR 25 0.0006
975 INJECTION SITE REACTION 43 0.0006
976 WITHDRAWAL SYNDROME 26 0.0006
977 DRUG ABUSE 50 0.0006
978 PRODUCT QUALITY ISSUE 78 0.0006
979 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
980 MULTIPLE SCLEROSIS 26 0.0005
981 EMOTIONAL DISTRESS 65 0.0005
982 MATERNAL EXPOSURE DURING PREGNANCY 46 0.0005
983 TREATMENT FAILURE 42 0.0005
984 DEVICE DIFFICULT TO USE 32 0.0005
985 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
986 SKIN BURNING SENSATION 31 0.0004
987 DRUG DOSE OMISSION BY DEVICE 26 0.0003
988 DRUG DEPENDENCE 37 0.0002